Peter Doshi BMJ C 19

Peter Doshi, PhD, is an associate professor
of pharmaceutical health services research at the University of
Maryland School of Pharmacy. His research focuses on the drug approval
process, how the risks and benefits of medical products are assessed and
communicated, and improving the credibility and accuracy of evidence
synthesis and biomedical publications. Doshi campaigns for greater
transparency of clinical trial data and has been advocating
for full transparency of the data on Covid-19 drugs and vaccines. Doshi
leads the Restoring Invisible and Abandoned Trials (RIAT) initiative,
which aims to ensure clinical trial publications are accurate, complete,
and data are publicly available. He completed a post-doctoral
fellowship in comparative effectiveness research at Johns Hopkins
University and received his Ph.D. in history, anthropology, and science,
technology and society from the Massachusetts Institute of Technology.